weight management glp-1 Drugs from the Gray Market Weight loss maintenance after discontinuing
Description
Ask your healthcare provider whether electrolyte drinks are appropriate for you
For research use onlynot for human use
In a phase 2 study, amycretin showed a mean weight reduction of up to 24.3%, which is comparable to or even greater than the weight loss seen with tirzepatide and similar to the results for retatrutide
This amount of weight loss has not been accomplished before with medical therapy
